Archives for May 2008
Squeaking Stryker Hip Implant
A story in the New York Times today sheds light on an increasingly common occurrence: squeaking hips.
A study in the Journal of Arthroplasty found that 7% of patients who received ceramic hips from 2003 to 2005 developed squeaks. No squeaks were found in a control group of 48 patients who received metal on plastic replacements.
Doctors […]
[Video Profile] Interview with Jim Dayton, Executive VP and Managing Director of Safeguard Scientifics
Safeguard Scientifics is a holding company that invests in growth-stage life sciences and technology. In addition to capital, Safeguard provides strategic, operational and management resources to its portfolio companies. As a public company (NYSE: SFE), Safeguard is not subject to the limits of the three-to-seven-year fund raising cycles found in venture capital or buyout firms. […]
NuVasive to Acquire Osteocel Biologics Business from Osiris Therapeutics
The $200 million NuVasive raised in a March offering may soon be put to good use. The company announced yesterday the pending acquisition of the Osteocel biologics business from Osiris Therapeutics.
Osteocel is a bone matrix product containing stem cells. Like an autograft, it is biologically active and provides the beneficial properties of osteoconduction, osteoinduction, and […]
NovaDel Announces $4 Million Financing
NovaDel entered into a private placement for up to $4 million, in the form of secured convertible promissory notes with an interest rate of 10% and warrants to purchase shares of the company’s common stock.
NovaDel intends to close on approximately $1.5 million in the initial closing upon AMEX approval and customary closing conditions. The balance […]
Myriad Goes Direct (Again)
Myriad Genetic Laboratories develops and markets proprietary predictive and personalized medicine products. This includes the poorly branded BRACAnalysis, to assess a woman’s risk of developing breast or ovarian cancer based on detection of mutations in the BRCA1 and BRCA2 genes. The test is reimbursed by most insurance carriers and is recommended for women with a […]
South Korean FDA Approves Cynosure’s Accolade Workstation for Pigmented Lesions
Although freckles occur most often in light skinned individuals with blond hair and blue eyes, freckles are also common among Asians, including Koreans. While they can look good, I’ve learned in my 25 years to never get between a woman and her happiness.
Cynosure, based in Westford, MA, offers an array of laser-based aesthetic treatment systems. […]
BioElectronics Corp. Merits a First Look
Most investors won’t touch a stock trading on the pink sheets with a ten foot medical device. But for the risk-inclined among you, BioElectronics Corp. (BIEL) may warrant a first look.
The company, which has gone largely unnoticed by investors, is trading near its year-long low, despite management initiatives that have already begun to pay off.
Based […]
[Video Profile] Interview with Ralph Makar, President & CEO of Bioject Medical
Bioject Medical develops and markets needle-free injection technology used to administer injectable medications.
Bioject’s technology works by forcing liquid medication at high speed through a tiny orifice (smaller than a human hair) held against the skin. This creates an ultra-fine stream of fluid that penetrates the skin in a fraction of a second. Several studies have […]
Bad News for Blood Substitutes
Blood substitutes don’t require refrigeration or cross-matching, have a long shelf life, and reduce the risk of iatrogenic infection. They could be a potentially lifesaving option for surgical and trauma patients with hemorrhagic shock, especially in rural areas and military settings where access to donor blood is limited.
Despite the potential advantages, clinical trials have raised […]
CryoLife on Firm Footing: EPS Increases, Revenues Up, Raises Guidance
Revenues at CryoLife rose 4% to $25.6 million in the first quarter of 2008. Net income was $2.8 million, or $0.10 per share, compared to $1.4 million, or $0.04 per share in Q1 2007.
Tissue processing revenues in Q1 2008 increased 4% to $13.4 million, primarily due to increased demand for the company’s cardiac and vascular […]
